Display options
Share it on

Cardiovasc Drugs Ther. 1995 Aug;9:533-7. doi: 10.1007/BF00877866.

Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease.

Cardiovascular drugs and therapy

T Störk, M Möckel, O Danne, H Völler, H Eichstädt, U Frei

Affiliations

  1. Department of Internal Medicine, Nephrology and Intensive Care Medicine, University Hospital Virchow Klinikum, Berlin, Germany.

PMID: 8562471 DOI: 10.1007/BF00877866

Abstract

Diastolic dysfunction is an early sign in the temporal sequence of ischemic events in coronary heart disease. The ischemic cascade, beginning with an oxygen demand supply imbalance and metabolic alterations, identifies diastolic disorders of the left ventricle (LV) as an early phenomenon, sometimes before systolic dysfunction, electrocardiographic changes, or chest pain occur. Although the physiology of diastolic function is complex, the factors contributing to diastolic disturbances can be differentiated into intrinsic and extrinsic LV abnormalities. Intrinsic mechanisms include (a) impaired LV relaxation, (b) the complex of LV hypertrophy, and (c) increased LV asynchrony. Myocardial hypertrophy leads to an increase of the myocardial mass/volume ratio, and the degree of hypertrophy is the main determinant of chamber stiffness. The main, if not unique, determinant of myocardial diastolic tissue distensibility is the structure and concentration of the collagen. Consequently, tissue stiffness is increased in coronary disease by reparative interstitial fibrosis or scar following myocardial infarction. In myocardial hypertrophy the LV collagen concentration is elevated due to reactive fibrosis. An increase in regional asynchrony of LV contraction and relaxation is a result of regional ischemia as well as of LV hypertrophy and tissue fibrosis. Factors extrinsic to the LV causing diastolic disorders include (a) increased central blood volume, which will increase left ventricular pressure without altering the LV pressure-volume relation, and (b) ventricular interaction mediated by pericardial restraint, which may cause a parallel upward shift of the diastolic LV pressure-volume relation. Improved insight into the mechanisms of LV relaxation and filling characteristics help in the treatment of LV diastolic dysfunction.

References

  1. J Hypertens Suppl. 1993 Jun;11(4):S3-9 - PubMed
  2. Lancet. 1986 Oct 25;2(8513):933-6 - PubMed
  3. J Cardiovasc Pharmacol. 1992;19 Suppl 5:S81-6 - PubMed
  4. J Am Coll Cardiol. 1988 Aug;12(2):426-40 - PubMed
  5. Circulation. 1984 Jan;69(1):190-6 - PubMed
  6. J Am Coll Cardiol. 1993 Sep;22(3):790-5 - PubMed
  7. Eur Heart J. 1992 Sep;13 Suppl D:2-8 - PubMed
  8. Circ Res. 1991 Jul;69(1):107-15 - PubMed
  9. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):49A-55A - PubMed
  10. N Engl J Med. 1990 May 31;322(22):1561-6 - PubMed
  11. Circulation. 1984 Apr;69(4):836-41 - PubMed
  12. Am J Cardiol. 1987 Mar 9;59(7):23C-30C - PubMed
  13. Mayo Clin Proc. 1989 Feb;64(2):181-204 - PubMed
  14. Z Kardiol. 1992 Jul;81(7):394-406 - PubMed
  15. Dtsch Med Wochenschr. 1992 May 22;117(21):807-14 - PubMed
  16. Eur J Appl Physiol Occup Physiol. 1994;68(6):451-9 - PubMed
  17. J Am Soc Echocardiogr. 1993 May-Jun;6(3 Pt 1):255-64 - PubMed
  18. Mayo Clin Proc. 1989 Jan;64(1):71-81 - PubMed
  19. Int J Sports Med. 1992 Nov;13(8):600-4 - PubMed
  20. Am Heart J. 1991 Apr;121(4 Pt 1):1244-63 - PubMed
  21. J Am Coll Cardiol. 1985 Apr;5(4):891-7 - PubMed
  22. Cardiovasc Res. 1989 Aug;23(8):655-61 - PubMed
  23. Am J Physiol. 1978 Jun;234(6):H653-9 - PubMed
  24. Ann Intern Med. 1992 Sep 15;117(6):502-10 - PubMed
  25. Circ Res. 1990 Dec;67(6):1355-64 - PubMed
  26. N Engl J Med. 1991 Aug 29;325(9):625-32 - PubMed
  27. J Am Coll Cardiol. 1993 Apr;21(5):1124-31 - PubMed
  28. Am J Cardiol. 1987 Apr 24;59(10 ):98D-103D - PubMed
  29. J Am Coll Cardiol. 1987 Feb;9(2):341-8 - PubMed

MeSH terms

Publication Types